QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
LON:ARIX

Arix Bioscience Share Forecast, Price & News

GBX 127
0.00 (0.00%)
(As of 01/24/2022 10:14 AM ET)
Add
Compare
Today's Range
122
129
50-Day Range
119
139
52-Week Range
118
211.40
Volume
174,272 shs
Average Volume
218,913 shs
Market Capitalization
£164.12 million
P/E Ratio
4.58
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive ARIX News and Ratings via Email

Sign-up to receive the latest news and ratings for Arix Bioscience and its competitors with MarketBeat's FREE daily newsletter.


Arix Bioscience logo

About Arix Bioscience

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.

Headlines

Arix Bioscience PLC: Notification of Major Share Holding
January 13, 2022 |  finanznachrichten.de
Notification of Major Share Holding
January 11, 2022 |  uk.finance.yahoo.com
Arix Bioscience (LON:ARIX) Trading Up 0.4%
January 8, 2022 |  americanbankingnews.com
Arix Bioscience Plc : Director/PDMR Shareholding
December 18, 2021 |  markets.businessinsider.com
Arix Bioscience PLC: Director/PDMR Shareholdings
December 17, 2021 |  markets.businessinsider.com
Arix Bioscience PLC: Depixus raises EUR30.6M -2-
December 16, 2021 |  finanznachrichten.de
Arix Bioscience PLC: Transaction in own shares -2-
November 10, 2021 |  finanznachrichten.de
Arix Bioscience PLC : Aura Biosciences prices Nasdaq IPO
November 1, 2021 |  markets.businessinsider.com
Aura Biosciences prices Nasdaq IPO
October 29, 2021 |  uk.finance.yahoo.com
TR1: Notification of Major Shareholding
October 13, 2021 |  uk.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Sales & Book Value

Annual Sales
£60.68 million
Cash Flow
GBX 136.24 per share
Book Value
GBX 222.80 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£164.12 million
Optionable
Not Optionable

Company Calendar

Today
1/24/2022
Next Earnings (Estimated)
3/09/2022

MarketRank

Overall MarketRank

2.23 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -












Arix Bioscience (LON:ARIX) Frequently Asked Questions

Is Arix Bioscience a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Arix Bioscience in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Arix Bioscience stock.
View analyst ratings for Arix Bioscience
or view top-rated stocks.

How has Arix Bioscience's stock price been impacted by COVID-19 (Coronavirus)?

Arix Bioscience's stock was trading at GBX 77 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ARIX shares have increased by 64.9% and is now trading at GBX 127.
View which stocks have been most impacted by COVID-19
.

When is Arix Bioscience's next earnings date?

Arix Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for Arix Bioscience
.

What price target have analysts set for ARIX?

3 brokerages have issued twelve-month price targets for Arix Bioscience's stock. Their forecasts range from GBX 256 to GBX 256. On average, they anticipate Arix Bioscience's share price to reach GBX 256 in the next year. This suggests a possible upside of 101.6% from the stock's current price.
View analysts' price targets for Arix Bioscience
or view top-rated stocks among Wall Street analysts.

Who are Arix Bioscience's key executives?

Arix Bioscience's management team includes the following people:
  • Mr. Robert Lyne, Interim CEO, Gen. Counsel, Company Sec. & Director
  • Mr. Marcus Karia, Group Fin. Director
  • Ms. Charlotte Parry, Head of Investor Relations
  • Dr. Christian Schetter, Managing Director (Age 57)
  • Mr. John Cassidy Ph.D., Principal
  • Mr. Tim Xu M.D., Principal
  • Mr. Noor Lalani, Public Markets Investment Director
  • Ms. Michelle Keating, Financial Controller
  • Dr. Gita Dittmar, Venture Partner
  • Mr. Felix Breyer Ph.D., Investment Analyst

What is Arix Bioscience's stock symbol?

Arix Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "ARIX."

How do I buy shares of Arix Bioscience?

Shares of ARIX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Arix Bioscience's stock price today?

One share of ARIX stock can currently be purchased for approximately GBX 127.

How much money does Arix Bioscience make?

Arix Bioscience has a market capitalization of £164.12 million and generates £60.68 million in revenue each year.

How many employees does Arix Bioscience have?

Arix Bioscience employs 12 workers across the globe.

What is Arix Bioscience's official website?

The official website for Arix Bioscience is arixbioscience.com.

Where are Arix Bioscience's headquarters?

Arix Bioscience is headquartered at 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom.

How can I contact Arix Bioscience?

Arix Bioscience's mailing address is 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom. The company can be reached via phone at +44-20-72901050.


This page was last updated on 1/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.